Form 8-K · Current Report · Filed 2024-11-22
Cardinal Health Announces Major Debt Offering and Loan Commitment Termination
Cardinal Health, Inc. announced the completion of a public offering of $2.9 billion aggregate principal amount of senior notes due in 2026, 2029, 2034, and 2054 to fund acquisitions and terminated the excess commitments under a bridge loan facility. The notes are governed by an indenture, and the company intends to use the proceeds for funding acquisition considerations and related fees and expenses. If the acquisition is not completed by the specified date, the company must redeem the notes at a special mandatory redemption price.
- Filer
- Cardinal Health Inc. CAH · NYSE
- Filed
- Accession
- 0001193125-24-264393
- CIK
- 0000721371
- Signal
- Medium impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Entry into a Material Definitive Agreement
Termination of a Material Definitive Agreement
Creation of a Direct Financial Obligation
Financial Statements and Exhibits
Market reaction
Close before filing
$123.42
Next session
-1.3%
Since filing
+86.4%
Latest close
$230.03
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from CAH reporting the same item, with the next session's move:
Exhibits (3)
About Cardinal Health Inc.
Cardinal Health Inc. is a major global healthcare services and products company, distinguished for providing end-to-end medical solutions. Specializing in healthcare distribution and supply chain management, Cardinal Health serves a comprehensive array of clients including hospitals, pharmacies, and healthcare providers. Notably, the company distributes pharmaceuticals, medical products, and laboratory supplies, ensuring efficient delivery to improve healthcare outcomes. Based in Dublin, Ohio, Cardinal Health plays a pivotal role in enhancing healthcare operational efficiency, offering extensive services like inventory management, logistics optimization, and integrated healthcare solutions that empower providers to focus on patient care. As one of the largest pharmaceutical distributors in the United States, it holds substantial influence in the healthcare sector, pivotal in ensuring the availability of drugs and medical supplies across various platforms, contributing significantly to the healthcare infrastructure worldwide.
Never miss another CAH filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.